{
  "id": "kidney-paired-donation",
  "title": "Kidney Paired Donation",
  "lang": "en",
  "source_lang": "en",
  "summary": "Kidney paired donation links living donors and recipients across different pairs so that recipients can receive compatible kidneys when direct donation is unsuitable.",
  "category": "health",
  "subcategory": "medicine",
  "type": "concept",
  "aliases": [
    "Kidney paired exchange",
    "Paired kidney exchange",
    "Kidney exchange",
    "KPD"
  ],
  "generated_at": "2026-11-04",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/kidney-paired-donation/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/kidney-paired-donation/",
      "json": "https://aiwiki.page/zh/kidney-paired-donation.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Kidney paired donation (KPD) is a form of living-donor organ transplantation in which donors give kidneys to recipients other than their originally intended recipients as part of a coordinated exchange. It most commonly enables transplantation when a willing donor and intended recipient are medically suitable for donation and transplantation individually but incompatible with one another. Exchanges may involve two pairs, several pairs in a cycle, or chains initiated by a donor who has no designated recipient."
    },
    {
      "heading": "Clinical purpose and compatibility",
      "text": "Kidney transplantation is a treatment for kidney failure, often resulting from advanced chronic kidney disease. A living donor can donate one kidney after medical and psychosocial evaluation. However, willingness to donate does not establish compatibility with a particular recipient.\n\nTwo important barriers are:\n\n- Blood-group incompatibility. Differences in the ABO blood-group system can cause the recipient’s antibodies to react against the donated kidney.\n- Donor-specific antibodies. A recipient may have antibodies against a donor’s human leukocyte antigens (HLA), creating a risk of antibody-mediated transplant rejection. Such antibodies can develop after a previous transplant, blood transfusion, or pregnancy.\n\nHLA differences alone do not necessarily prevent transplantation. The presence and characteristics of donor-specific antibodies, together with other clinical findings, are important in assessing immunological risk.\n\nA crossmatch assesses whether a recipient has antibodies that react with a prospective donor. A laboratory crossmatch tests recipient serum against donor cells; a virtual crossmatch compares the recipient’s known antibody profile with the donor’s HLA typing.\n\nPaired donation changes the donor–recipient combination rather than attempting to overcome the original incompatibility. In some programs, already compatible pairs also participate to seek a more suitable match or help facilitate additional transplants. Participation does not guarantee that a suitable exchange will be found."
    },
    {
      "heading": "Exchange structures",
      "text": "Two-pair exchange\n\nThe simplest exchange involves two donors and their intended recipients. Donor A cannot donate directly to recipient A but can donate to recipient B. Donor B, in turn, can donate to recipient A.\n\nEach recipient therefore receives a kidney from the other pair’s donor. The donors need not be biologically related to their intended recipients or to the people who receive their kidneys.\n\nMulti-pair cycles\n\nA cycle can include three or more pairs. For example, donor A gives to recipient B, donor B gives to recipient C, and donor C gives to recipient A.\n\nOperations within a cycle are commonly coordinated to occur simultaneously or within a tightly controlled period. This reduces the risk that one donor withdraws after that donor’s intended recipient has already received a kidney, leaving another recipient without the expected transplant. Larger cycles require more operating rooms, surgical teams, and logistical coordination.\n\nDonation chains\n\nA chain begins with a non-directed living donor: someone who donates without naming a particular recipient. That donor gives to a recipient in a participating pair, whose associated donor then gives to another recipient, and so on.\n\nUnlike a cycle, a chain does not have to return a kidney to its starting point. Depending on program rules, it may end with a transplant to someone on the deceased-donor waiting list or pause with a bridge donor—a donor expected to continue the chain later.\n\nChains can be performed in stages rather than entirely simultaneously. This makes longer sequences feasible but introduces the possibility that a bridge donor becomes unable or unwilling to proceed."
    },
    {
      "heading": "Matching and coordination",
      "text": "Exchange programs collect information about donors and recipients, including blood group, HLA typing, antibody profiles, medical suitability, and practical constraints. Matching software identifies potentially compatible combinations.\n\nThe matching problem can be represented as a directed graph: each donor–recipient pair is a node, and an arrow indicates that one pair’s donor could donate to another pair’s recipient. Algorithms and mathematical optimization methods identify feasible cycles and chains.\n\nPrograms may consider several objectives, including:\n\n- Maximizing the number of transplants.\n- Improving access for candidates who are difficult to match.\n- Accounting for immunological compatibility and donor–recipient characteristics.\n- Limiting chain length, transport time, and scheduling complexity.\n- Reducing the likelihood that an exchange fails before completion.\n\nA computer-generated match is provisional. Clinical teams must confirm compatibility, donor suitability, recipient readiness, and consent before surgery. New illness, changes in antibody profiles, or withdrawal can prevent a proposed exchange from proceeding.\n\nLarger pools generally offer more matching opportunities, but some candidates remain difficult to match. These include highly sensitized recipients with antibodies against many potential donors and certain combinations of donor and recipient blood groups."
    },
    {
      "heading": "Transplantation and follow-up",
      "text": "Paired donation uses the same basic donor evaluation, kidney-removal procedures, and transplant operations as other living-donor kidney transplantation. It changes allocation and coordination rather than the surgical principle.\n\nSome programs arrange donor travel; others transport kidneys between transplant centers. Transport requires controlled preservation and coordination to limit the time the kidney remains without a blood supply. Whether travel or organ shipment is used depends on geography, program organization, and clinical circumstances.\n\nRecipients ordinarily require continuing immunosuppressive treatment and monitoring after transplantation. A compatible exchange does not eliminate rejection, infection, or other transplant risks. Donors also require follow-up after donation; participation in an exchange does not remove the risks associated with living kidney donation."
    },
    {
      "heading": "Benefits and limitations",
      "text": "Paired donation can make living-donor transplantation possible for recipients whose original donors are incompatible. It may reduce time spent waiting for a transplant or receiving dialysis, although the benefit depends on whether and when a suitable match becomes available.\n\nFor some pairs, it provides an alternative to transplantation across an antibody or blood-group barrier. Some programs combine exchange with treatments intended to reduce antibody-related barriers, so the approaches are not always mutually exclusive.\n\nImportant limitations include:\n\n- Unequal matching opportunities: some immunological profiles and blood-group combinations remain difficult to accommodate.\n- Coordination failures: medical changes, withdrawal, or transport and scheduling problems can interrupt an exchange.\n- Limited availability: access depends on participating centers, registry size, funding, and national rules.\n- Uncertain timing: enrollment does not establish a predictable transplant date.\n\nPaired donation does not create a living donor for a person who has none. However, some donation chains extend access by ending with a transplant to a candidate on the deceased-donor waiting list."
    },
    {
      "heading": "Ethics and governance",
      "text": "Paired donation is based on voluntary organ donation, not the purchase or sale of kidneys. Its ethical safeguards include informed consent, assessment for coercion, confidential donor evaluation, and protection of a donor’s right to withdraw.\n\nWithdrawal is especially sensitive because one decision may affect several participants. Programs therefore need procedures for managing disrupted exchanges without treating a donor’s participation as an enforceable obligation.\n\nOther governance issues include protection of medical information, allocation priorities, reimbursement of legitimate donation-related expenses, and equitable access across transplant centers and patient groups. Cross-border exchanges add differences in legal requirements, financing, donor protection, and follow-up arrangements."
    },
    {
      "heading": "Development",
      "text": "The concept was proposed in the medical literature in the 1980s, and clinical exchanges began in the following decade. Programs subsequently expanded from local exchanges to regional and national networks. Non-directed donor chains, computerized matching, and coordinated kidney transport have enabled exchanges involving multiple transplant centers. Organizational models differ: some systems use a national registry, while others operate through several networks."
    }
  ],
  "links": [
    "organ-transplantation",
    "chronic-kidney-disease",
    "kidney",
    "abo-blood-group-system",
    "antibody",
    "human-leukocyte-antigen",
    "transplant-rejection",
    "blood-transfusion",
    "pregnancy",
    "transplant-crossmatch",
    "algorithm",
    "mathematical-optimization",
    "immunosuppression",
    "dialysis",
    "organ-donation",
    "health-equity"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}